Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non-Current Assets (2017 - 2025)

Protagonist Therapeutics' Other Non-Current Assets history spans 9 years, with the latest figure at $287000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 27.56% year-over-year to $287000.0; the TTM value through Dec 2025 reached $287000.0, up 27.56%, while the annual FY2025 figure was $287000.0, 27.56% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $287000.0 at Protagonist Therapeutics, roughly flat from $287000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $290000.0 in Q2 2025 and bottomed at $225000.0 in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $225000.0 (2021), against an average of $234450.0.
  • The largest annual shift saw Other Non-Current Assets tumbled 50.0% in 2021 before it rose 28.89% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $225000.0 in 2021, then changed by 0.0% to $225000.0 in 2022, then changed by 0.0% to $225000.0 in 2023, then changed by 0.0% to $225000.0 in 2024, then rose by 27.56% to $287000.0 in 2025.
  • Per Business Quant, the three most recent readings for PTGX's Other Non-Current Assets are $287000.0 (Q4 2025), $287000.0 (Q3 2025), and $290000.0 (Q2 2025).